ADCT · ADC Therapeutics SA · Documents
$1.52
+0.08 (+5.56%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$190.22M
Shares
127.67M
Volume · Oct 20
1.06M
Avg daily vol (3M)
1.52M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-05-14 | — | |
| 8-K | — | 2024-05-08 | 2024-05-06 | |
| 10-Q | — | 2024-05-06 | 2024-03-31 | |
| 8-K | — | 2024-05-06 | — | |
| DEF 14A | — | 2024-04-26 | 2024-06-13 | |
| DEFA14A | — | 2024-04-26 | — | |
| PRE 14A | — | 2024-04-16 | 2024-06-13 | |
| 8-K | — | 2024-04-09 | — | |
| ARS | — | 2024-03-13 | 2023-12-31 | |
| 10-K | — | 2024-03-13 | 2023-12-31 | |
| 8-K | — | 2024-03-13 | — | |
| 8-K | — | 2024-03-05 | — | |
| 8-K | — | 2024-02-29 | 2024-02-23 | |
| 8-K | — | 2024-01-24 | 2024-01-18 | |
| 8-K | — | 2024-01-19 | 2024-01-16 | |
| 8-K | — | 2024-01-04 | — | |
| 8-K | — | 2024-01-04 | — | |
| 6-K | — | 2023-12-19 | — | |
| 6-K | — | 2023-11-07 | 2023-09-30 | |
| 6-K | — | 2023-11-07 | — | |
| 6-K | — | 2023-09-11 | — | |
| 6-K | — | 2023-08-31 | 2023-08-30 | |
| 6-K | — | 2023-08-08 | 2023-06-30 | |
| 6-K | — | 2023-07-20 | — | |
| 6-K | — | 2023-07-11 | — | |
| 6-K | — | 2023-06-14 | — | |
| 6-K | — | 2023-05-09 | 2023-03-31 | |
| 6-K | — | 2023-05-05 | — | |
| SC TO-I/A | — | 2023-04-05 | — | |
| SC TO-I/A | — | 2023-03-30 | — | |
| SC TO-I/A | — | 2023-03-29 | — | |
| SC TO-I/A | — | 2023-03-17 | — | |
| F-3 | — | 2023-03-15 | — | |
| 6-K | — | 2023-03-15 | 2022-12-31 | |
| 20-F | — | 2023-03-15 | 2022-12-31 | |
| 6-K | — | 2023-03-13 | — | |
| SC TO-I | — | 2023-03-06 | — | |
| SC TO-C | — | 2023-03-03 | — | |
| 6-K | — | 2023-02-28 | — | |
| 6-K | — | 2023-02-06 | — | |
| 6-K | — | 2023-02-02 | — | |
| 6-K | — | 2023-01-09 | — | |
| 6-K | — | 2023-01-04 | — | |
| 6-K | — | 2023-01-04 | — | |
| 6-K | — | 2022-12-21 | — | |
| 6-K | — | 2022-12-19 | — | |
| 6-K | — | 2022-11-08 | 2022-09-30 | |
| 6-K | — | 2022-11-07 | — | |
| 6-K | — | 2022-11-03 | — | |
| 6-K | — | 2022-11-02 | — |
Showing 51–100 of 212 filings
Key facts
CIK
1771910
CUSIP
H0036K147
13F (30d)
10 filings
10 filers
Visit website
Investor relations